Khalil Haji-Asgarzadeh (Khalil Hajiasgharzadeh)

Scopus Author ID ResearcherID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 12

Top Venues

Journal of cellular physiology

Advanced pharmaceutical bulletin

Immunological investigations

Cancers

Tabriz University of Medical Sciences

Tarbiat Modares University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Tabriz University of Medical Sciences

Iran

Researcher :: Immunology Research Center

Education History

Tarbiat Modares University

Iran

PHD :: Physiology

Publications

Bita Amir Taghavi, Nazila Alizadeh, Hossein Saeedi, Noora Karim Ahangar, Afshin Derakhshani, Khalil Haji-Asgarzadeh, Nicola Silvestris, Behzad Baradaran, Oronzo Brunetti
Targeted Therapy of B7 Family Checkpoints as an Innovative Approach to Overcome Cancer Therapy Resistance: A Review from Chemotherapy to Immunotherapy. Molecules (Basel, Switzerland) 27 (11) (2022)
Masoud Nouri-Vaskeh, Leila Alizadeh, Khalil Haji-Asgarzadeh, Ahad Mokhtarzadeh, Monireh Halimi, Behzad Baradaran
The role of HSP90 molecular chaperones in hepatocellular carcinoma. Journal of cellular physiology 235 (12) (2020)
Zeynab Aaliyari-Serej, Ayyub Ebrahimi, Balal Barazvan, Abbas Ebrahimi-Kalan, Khalil Haji-Asgarzadeh, Tohid Kazemi, Behzad Baradaran
Recent Advances in Targeting of Breast Cancer Stem Cells Based on Biological Concepts and Drug Delivery System Modification. Advanced pharmaceutical bulletin 10 (3) (2020)
Parisa Lotfinejad, Zahra Asadzadeh, Shiva Najjary, Mohammad Hossein Somi, Khalil Haji-Asgarzadeh, Ahad Mokhtarzadeh, Afshin Derakhshani, Elmira Roshani, Behzad Baradaran
COVID-19 Infection: Concise Review Based on the Immunological Perspective. Immunological investigations (2020)
Elshan Bajhan, Behzad Mansoori, Ali Mohammadi, Dariush Shanehbandi, Vahid Khaze Shahgoli, Elham Baghbani, Khalil Haji-Asgarzadeh, Behzad Baradaran
MicroRNA-143 inhibits proliferation and migration of prostate cancer cells. Archives of physiology and biochemistry (2020)
Elnaz Faghfuri, Farhad Pourfarzi, Amir Hossein Faghfouri, Mahdi Abdoli Shadbad, Khalil Haji-Asgarzadeh, Behzad Baradaran
Recent developments of RNA-based vaccines in cancer immunotherapy. Expert opinion on biological therapy 21 (2) (2020)
Negar Hosseinkhani, Afshin Derakhshani, Omid Kooshkaki, Mahdi Abdoli Shadbad, Khalil Haji-Asgarzadeh, Amir Baghbanzadeh, Hossein Safarpour, Ahad Mokhtarzadeh, Oronzo Brunetti, Simon C Yue, Nicola Silvestris, Behzad Baradaran
Immune Checkpoints and CAR-T Cells: The Pioneers in Future Cancer Therapies? International journal of molecular sciences 21 (21) (2020)
Zahra Asadzadeh, Elham Safarzadeh, Sahar Safaei, Ali Baradaran, Ali Mohammadi, Khalil Haji-Asgarzadeh, Afshin Derakhshani, Antonella Argentiero, Nicola Silvestris, Behzad Baradaran
Current Approaches for Combination Therapy of Cancer: The Role of Immunogenic Cell Death. Cancers 12 (4) (2020)
Zahra Payandeh, Saeed Khalili, Mohammad Hossein Somi, Maysam Mard-Soltani, Amir Baghbanzadeh, Khalil Haji-Asgarzadeh, Nasser Samadi, Behzad Baradaran
PD-1/PD-L1-dependent immune response in colorectal cancer. Journal of cellular physiology 235 (7-8) (2020)
Khalil Haji-Asgarzadeh, Saeed Sadigh-Eteghad, Behzad Mansoori, Ahad Mokhtarzadeh, Dariush Shanehbandi, Mohammad Amin Doustvandi, Zahra Asadzadeh, Behzad Baradaran
Alpha7 nicotinic acetylcholine receptors in lung inflammation and carcinogenesis: Friends or foes? Journal of cellular physiology (2019)
Khalil Haji-Asgarzadeh, Mohammad Hossein Somi, Behzad Mansoori, Mohammad Amin Doustvandi, Fatemeh Vahidian, Mohsen Alizadeh, Ahad Mokhtarzadeh, Dariush Shanehbandi, Behzad Baradaran
Alpha7 Nicotinic Acetylcholine Receptor Mediates Nicotine-induced Apoptosis and Cell Cycle Arrest of Hepatocellular Carcinoma HepG2 Cells. Advanced pharmaceutical bulletin 10 (1) (2019)
Zahra Asadzadeh, Behzad Mansoori, Ali Mohammadi, Marjan Aghajani, Khalil Haji-Asgarzadeh, Elham Safarzadeh, Ahad Mokhtarzadeh, Pascal H G Duijf, Behzad Baradaran
microRNAs in cancer stem cells: Biology, pathways, and therapeutic opportunities. Journal of cellular physiology 234 (7) (2018)

Khalil Haji-Asgarzadeh.css-eqlu8i{font-size:small;padding-left:4px;} (Khalil Hajiasgharzadeh)

Publication Activity (10 Years)

Top Topics

Top Venues

Khalil Haji-Asgarzadeh (Khalil Hajiasgharzadeh)